Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,553.30
-6.80 (-0.44%)
May 8, 2026, 3:30 PM IST
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 393.9 billion as of May 8, 2026. Its market cap has increased by 10.55% in one year.
Market Cap
393.90B
Enterprise Value
408.53B
Revenue
95.06B
Ranking
n/a
PE Ratio
42.86
Stock Price
1,553.30
Market Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 393.90B, an increase of 12,137.71%. That is a compound annual growth rate of 22.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 393.90B | 9.42% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 667.83B |
| Glenmark Pharmaceuticals | 667.80B |
| Laurus Labs | 663.11B |
| Ajanta Pharma | 379.03B |
| Gland Pharma | 313.76B |
| Emcure Pharmaceuticals | 311.50B |
| Wockhardt | 261.04B |
| Piramal Pharma | 238.81B |